IBDEI1G9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25994,1,3,0)
 ;;=3^344.1
 ;;^UTILITY(U,$J,358.3,25994,1,4,0)
 ;;=4^SCI - Para
 ;;^UTILITY(U,$J,358.3,25995,0)
 ;;=344.00^^148^1575^4
 ;;^UTILITY(U,$J,358.3,25995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25995,1,3,0)
 ;;=3^344.00
 ;;^UTILITY(U,$J,358.3,25995,1,4,0)
 ;;=4^Quadriplegia
 ;;^UTILITY(U,$J,358.3,25995,2)
 ;;=Quadriplegia^101908
 ;;^UTILITY(U,$J,358.3,25996,0)
 ;;=359.9^^148^1575^2
 ;;^UTILITY(U,$J,358.3,25996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25996,1,3,0)
 ;;=3^359.9
 ;;^UTILITY(U,$J,358.3,25996,1,4,0)
 ;;=4^Myopathy NOS
 ;;^UTILITY(U,$J,358.3,25996,2)
 ;;=Myopathy NOS^79927
 ;;^UTILITY(U,$J,358.3,25997,0)
 ;;=358.00^^148^1575^1
 ;;^UTILITY(U,$J,358.3,25997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25997,1,3,0)
 ;;=3^358.00
 ;;^UTILITY(U,$J,358.3,25997,1,4,0)
 ;;=4^Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,25997,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,25998,0)
 ;;=578.9^^148^1576^1
 ;;^UTILITY(U,$J,358.3,25998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25998,1,3,0)
 ;;=3^578.9
 ;;^UTILITY(U,$J,358.3,25998,1,4,0)
 ;;=4^GI Bleeding
 ;;^UTILITY(U,$J,358.3,25999,0)
 ;;=455.6^^148^1576^2
 ;;^UTILITY(U,$J,358.3,25999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25999,1,3,0)
 ;;=3^455.6
 ;;^UTILITY(U,$J,358.3,25999,1,4,0)
 ;;=4^Hemmorrhoids/Fissure
 ;;^UTILITY(U,$J,358.3,26000,0)
 ;;=553.9^^148^1576^3
 ;;^UTILITY(U,$J,358.3,26000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26000,1,3,0)
 ;;=3^553.9
 ;;^UTILITY(U,$J,358.3,26000,1,4,0)
 ;;=4^Hernia
 ;;^UTILITY(U,$J,358.3,26001,0)
 ;;=533.90^^148^1576^4
 ;;^UTILITY(U,$J,358.3,26001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26001,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,26001,1,4,0)
 ;;=4^Peptic Ulcer Dis
 ;;^UTILITY(U,$J,358.3,26001,2)
 ;;=Peptic Ulcer Dis^93051
 ;;^UTILITY(U,$J,358.3,26002,0)
 ;;=571.5^^148^1577^4
 ;;^UTILITY(U,$J,358.3,26002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26002,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,26002,1,4,0)
 ;;=4^Cirrohosis
 ;;^UTILITY(U,$J,358.3,26003,0)
 ;;=790.6^^148^1577^1
 ;;^UTILITY(U,$J,358.3,26003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26003,1,3,0)
 ;;=3^790.6
 ;;^UTILITY(U,$J,358.3,26003,1,4,0)
 ;;=4^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,26003,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,26004,0)
 ;;=070.1^^148^1577^5
 ;;^UTILITY(U,$J,358.3,26004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26004,1,3,0)
 ;;=3^070.1
 ;;^UTILITY(U,$J,358.3,26004,1,4,0)
 ;;=4^Hepatitis A w/o Coma
 ;;^UTILITY(U,$J,358.3,26004,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,26005,0)
 ;;=070.30^^148^1577^6
 ;;^UTILITY(U,$J,358.3,26005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26005,1,3,0)
 ;;=3^070.30
 ;;^UTILITY(U,$J,358.3,26005,1,4,0)
 ;;=4^Hepatitis B w/o Coma or Delta
 ;;^UTILITY(U,$J,358.3,26005,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,26006,0)
 ;;=V02.62^^148^1577^7
 ;;^UTILITY(U,$J,358.3,26006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26006,1,3,0)
 ;;=3^V02.62
 ;;^UTILITY(U,$J,358.3,26006,1,4,0)
 ;;=4^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,26006,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,26007,0)
 ;;=070.51^^148^1577^2
 ;;^UTILITY(U,$J,358.3,26007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26007,1,3,0)
 ;;=3^070.51
 ;;^UTILITY(U,$J,358.3,26007,1,4,0)
 ;;=4^Acute Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,26007,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,26008,0)
 ;;=070.54^^148^1577^3
 ;;^UTILITY(U,$J,358.3,26008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26008,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,26008,1,4,0)
 ;;=4^Chr Hepatitis C w/o Coma
